Skip to content
  1. Home/
  2. Latest news/
  3. Health & wellness/
  4. Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

Helping Babies Breathe

A quadruplet baby from the Shen family who needed neonatal resuscitation at birth

Childbirth should be a moment to celebrate the miracle of life, but as many as 1 in 10 newborns are unable to breathe upon entering the world.

The condition, known as birth asphyxia, is among the world’s leading causes of infant death. And a decade ago, it accounted for 20% of China’s infant mortality rate—that’s a shocking 73,000 babies lost each year.

But a simple, low-tech medical technique called neonatal resuscitation can help prevent it. That’s why Johnson & Johnson partnered with the Chinese Ministry of Health and other organizations in an effort to ensure that caregivers in every Chinese hospital received the training they needed to administer the procedure.

Ten years later, we’re proud to say that this unique public/private partnership, known as “Freedom of Breath, Fountain of Life,” has helped over 100,000 Chinese babies take their first breath. And after a decade of success, we’re committed to keeping the partnership going for another five years.

But don’t just take our word for it: Watch the moving video below and meet six kids who are alive and thriving, thanks to the historic partnership that empowered everyone from midwives to doctors to save precious lives.

hqdefault.jpg
Celebrating Life, One Breath at a Time

More from Johnson & Johnson

Johnson & Johnson named a 2025 Fortune World’s Most Admired Company

A dedication to innovation and social responsibility are just two of the qualities that helped the company garner a coveted spot on the list for the 23rd year in a row.

What you need to know about Johnson & Johnson’s 2024 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and full-year performance, with highlights from its Innovative Medicine and MedTech businesses.

5 things we now know about eczema (a.k.a., atopic dermatitis)

The most common inflammatory skin disease causes scaly patches, blisters and severe itching, but it’s far more than just a cosmetic concern. Learn why Johnson & Johnson is focused on helping the millions living with this painful condition.